Top Stories

Tesla's Robotaxi To Be Called 'Cybercab?' Elon Musk Says Self-Driving Fleet Will Be Like 'Combination Of Airbnb And Uber'
US Congress Finally Passes $95B Foreign Aid Bill For Ukraine, Israel, Taiwan Amid Simmering Russian Aggression
Tesla's High-Profile Departures Continue As Investor Relations Head Martin Viecha Bids Farewell After 7-Year Run
US Congress Finally Passes $95B Foreign Aid Bill For Ukraine, Israel, Taiwan Amid Simmering Russian Aggression
Tesla's High-Profile Departures Continue As Investor Relations Head Martin Viecha Bids Farewell After 7-Year Run
David Pecker Testifies To National Enquirer Buying Stories That Could Damage Donald Trump: 'Potential Embarrassment To The Campaign'
Non-Compete Clauses Are A Thing Of The Past, At Least For Now: FTC Issues Landmark Ban, Chamber Of Commerce Plans To Sue

Top Stories Recent News

Tesla Q1 Earnings Highlights: EV Giant Misses Wall Street Estimates, Makes Cost Cuts, Invests In AI, Speeds Launch Of New Models
Key highlights from the first-quarter earnings report from Tesla.
Copper Prices Approach 2-Year Highs: What's Behind Analyst's $12,000 Price Prediction For 2026?
Copper prices have surged due to increased demand from electric vehicles, AI, and power infrastructure. Analysts predict a supply deficit and potential for even higher prices.
Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert (Updated)
WHO alerts the global community about tainted children's cough syrup by Johnson & Johnson. Elevated toxin levels detected in Benylin syrup prompt recalls across Africa. Investigation is underway.
Did The Fed's Strategy Pay Off? Goldman Sachs Projects Steady Inflation Decline In 2024
Goldman Sachs predicts core PCE inflation to decrease to 2.2% by end of 2024, citing decreases in consumer electronics and financial services prices.
Crypto Influencer Goes Viral Pointing Out 'How Market Makers Manipulate Prices'
Pseudonymous cryptocurrency influencer Rekt Fencer highlighted in a viral thread on X (formerly Twitter) how market makers manipulate prices and help traders to make millions.
Elon Musk Slips From Richest Person Ranking After Losing Billions In Recent Months: Who's Now Richer?
Elon Musk was once the richest person due to Tesla's high stock price, but suffered the largest loss in history. He remains in the top five.
UBS Upgrades China Stocks Amid 'Valuation Collapse': What Investors Need to Know
UBS Group AG has upgraded China's stock market to Overweight, citing resilient earnings and state fund interventions. Other Asian markets downgraded.
Patient Data Compromised - UnitedHealth Group Admits Ransom Payment in Cyberattack
UnitedHealth Group disclosed ransom payments after the cyberattack on Change Healthcare. Breach exposes personal data, impacting millions. The company cooperates with law enforcement for a thorough investigation.
Here's How Much Warren Buffett Could Have Made Investing In Tesla
Berkshire Hathaway passed on investing in Tesla in 2009. That investment could have turned into a sizable return for the Warren Buffett led company.
FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors
Discover Novartis' FDA approval for Lutathera in pediatric patients with GEP-NETs, marking a pivotal milestone in treating this rare cancer. Explore its efficacy in combating SSTR+ tumors, backed by robust trial data.
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown
Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmaceutical landscape, impacting future innovations and revenue streams.
Will Rupert Murdoch Dump The WSJ? Politico, Business Insider Owner Licks His Lips While Bill Ackman Battle Casts Huge Shadow (UPDATED)
German media company Axel Springer could be looking to grow its presence in the United States, but has a potential legal storm with Bill Ackman still unsettled.
Treatment Patch For Schizophrenia: Newly Listed Alto Neuroscience Is Uniquely Positioned In Neuropsychiatry Landscape
Alto Neuroscience reported positive results for its novel PDE4 inhibitor in a Phase 1 study for cognitive impairment associated with schizophrenia.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers